PL3643325T3 - Kompozycja farmaceutyczna zawierająca furazydynę i sposób jej wytwarzania - Google Patents

Kompozycja farmaceutyczna zawierająca furazydynę i sposób jej wytwarzania

Info

Publication number
PL3643325T3
PL3643325T3 PL19209609.7T PL19209609T PL3643325T3 PL 3643325 T3 PL3643325 T3 PL 3643325T3 PL 19209609 T PL19209609 T PL 19209609T PL 3643325 T3 PL3643325 T3 PL 3643325T3
Authority
PL
Poland
Prior art keywords
furazidin
manufacturing
composition
Prior art date
Application number
PL19209609.7T
Other languages
English (en)
Inventor
Piotr PADUSZYŃSKI
Katarzyna Częścik
Piotr Potaczek
Małgorzata Han-Marek
Tomasz HAN
Stanisław HAN
Original Assignee
Przedsiębiorstwo Produkcji Farmaceutycznej Hasco-Lek S.A.
Centrum Badawczo-Rozwojowe Novasome sp. z o.o.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL419047A external-priority patent/PL234271B1/pl
Priority claimed from PL421505A external-priority patent/PL234395B1/pl
Application filed by Przedsiębiorstwo Produkcji Farmaceutycznej Hasco-Lek S.A., Centrum Badawczo-Rozwojowe Novasome sp. z o.o. filed Critical Przedsiębiorstwo Produkcji Farmaceutycznej Hasco-Lek S.A.
Publication of PL3643325T3 publication Critical patent/PL3643325T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL19209609.7T 2016-10-10 2017-10-06 Kompozycja farmaceutyczna zawierająca furazydynę i sposób jej wytwarzania PL3643325T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL419047A PL234271B1 (pl) 2016-10-10 2016-10-10 Doustna kompozycja farmaceutyczna zawierająca furazydynę w postaci zawiesiny oraz sposoby jej wytwarzania
PL421505A PL234395B1 (pl) 2017-05-08 2017-05-08 Doustna kompozycja farmaceutyczna zawierająca furazydynę i sposób jej wytwarzania

Publications (1)

Publication Number Publication Date
PL3643325T3 true PL3643325T3 (pl) 2024-06-24

Family

ID=60302423

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19209609.7T PL3643325T3 (pl) 2016-10-10 2017-10-06 Kompozycja farmaceutyczna zawierająca furazydynę i sposób jej wytwarzania

Country Status (4)

Country Link
EP (2) EP3643325B1 (pl)
PL (1) PL3643325T3 (pl)
RU (1) RU2019110218A (pl)
WO (1) WO2018069804A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL236891B1 (pl) * 2017-06-21 2021-02-22 Aflofarm Farm Polska Spolka Z Ograniczona Odpowiedzialnoscia Płynna forma podawania furazydyny oraz sposób jej otrzymywania
HUE071463T2 (hu) * 2021-01-25 2025-08-28 Adamed Pharma S A Elnyújtott hatóanyag-leadású furazidinkészítmény
EP4545074A1 (en) 2023-10-27 2025-04-30 Adamed Pharma S.A. Pharmaceutical composition of furazidin for vaginal administration

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500516A (en) * 1982-10-22 1985-02-19 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr Antibacterial pharmaceutical composition
RU2103997C1 (ru) * 1995-04-19 1998-02-10 Акционерное общество закрытого типа "Гекта" Лекарственное средство для лечения заболеваний животных микробной этиологии, способ лечения желудочно-кишечных заболеваний животных микробной этиологии и способы лечения гинекологических заболеваний коров микробной этиологии
RU2626671C2 (ru) * 2015-08-05 2017-07-31 Федеральное государственное бюджетное образовательное учреждение высшего образования "Нижегородская государственная медицинская академия" Министерства здравоохранения Российской Федерации (ФГБОУ ВО НижГМА Минздрава России) Лекарственное средство для лечения поражений мягких тканей организма

Also Published As

Publication number Publication date
EP3522929A2 (en) 2019-08-14
WO2018069804A2 (en) 2018-04-19
EP3643325B1 (en) 2024-04-10
WO2018069804A3 (en) 2018-07-19
EP3643325C0 (en) 2024-04-10
RU2019110218A3 (pl) 2021-03-30
RU2019110218A (ru) 2020-11-13
EP3643325A1 (en) 2020-04-29

Similar Documents

Publication Publication Date Title
SG11202004253QA (en) Oil-and-fat composition and manufacturing method thereof
PL3206816T3 (pl) Sposób wytwarzania elementu składowego i element składowy
GB2526633B (en) Garment and method of manufacturing same
PL3484318T3 (pl) Czapka z daszkiem i sposób wytwarzania czapki z daszkiem
PT3036748T (pt) Indutor e respetivo método de fabrico
PL3377146T3 (pl) Mikropompa i sposób wytwarzania mikropompy
ZA201906944B (en) Methods of manufacturing of niraparib
PL3178980T3 (pl) Materiał włókienniczy oraz sposób wytwarzania materiału włókienniczego
GB201716774D0 (en) Method of manufacturing fluorescent-material-containing member
EP3116069A4 (en) Terminal and method of manufacturing a terminal
SG10201607486YA (en) Improved packaging and method of manufacturing same
GB201604320D0 (en) Display and method of manufacturing same
PL3127605T3 (pl) Sposób wytwarzania wypełnienia oraz wypełnienie
SG11201609688QA (en) Formed material manufacturing method and formed material
GB2548706B (en) Method of manufacturing fluorescent-material-containing member
SG11201507205UA (en) Formed material manufacturing method and formed material
SG10201912645TA (en) Free-polyunsaturated-fatty-acid-containing composition and method for manufacturing same
SI3325839T1 (sl) Oblikovani material in postopek proizvodnje
PL3643325T3 (pl) Kompozycja farmaceutyczna zawierająca furazydynę i sposób jej wytwarzania
SG11202006477WA (en) Methionine-metal chelate and manufacturing method thereof
GB201603001D0 (en) A bearing raceaway and a method of manufacturing a bearing
GB201503137D0 (en) A decal and a method of manufacturing same
SG11202000339WA (en) Methionine-Metal Chelate and Manufacturing Method thereof
GB201501413D0 (en) A confectionery composition and a method of manufacturing thereof
GB2552007C (en) Horseshoe and method of manufacturing a horseshoe